Epigenetic study for new head and neck cancer treatments
Part of Cancer clinical trials.
This trial studies the role of epigenetic marks in head and neck cancer to improve diagnosis and treatment. If you have been newly diagnosed with head and neck squamous cell carcinoma and have not yet received treatment, you may be eligible to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with head and neck squamous cell carcinoma (a common type of head and neck cancer).
- Your tumor has not been treated with any therapy yet (no prior radiotherapy, chemotherapy, or immunotherapy for head and neck cancer).
- Your tumor is in the mouth, voice box, or throat.
- You are able to provide written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects tissue and health information to find the best treatment for your head and neck cancer. It may help guide your care by looking at the genetic details of your tumor.
This trial tries a more personalized treatment approach for people with locally advanced head and neck cancers by testing their tumor and blood for cancer “genetic” clues. If you may be eligible, you would have fresh tumor (and possibly lymph node) biopsies at the start and again if the cancer returns, plus blood tests to guide research and future study options.
This study collects tissue from people with newly diagnosed head and neck squamous cell cancer and grows “mini tumor models” in the lab. The goal is to see how these models respond to new therapies, which may help guide more effective treatment choices in the future.
This study aims to find signs of head and neck cancer coming back early, using scans/tests after you’ve had radical treatment. If you’re at higher risk and HPV-negative, this may help doctors catch relapse sooner.
This study focuses on testing a personalized immune therapy (made from your tumor-fighting T cells) for people with head and neck cancer. It may help patients whose cancer is new and untreated or whose cancer has come back or is not responding to standard options.
This study compares gene patterns in tumor tissue and blood samples from patients with HPV-negative head and neck cancer. Understanding these patterns may help doctors better understand the disease and develop better treatments.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.